These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
263 related articles for article (PubMed ID: 21604178)
1. Current and novel renal biomarkers in heart failure. Damman K; Voors AA; Navis G; van Veldhuisen DJ; Hillege HL Heart Fail Rev; 2012 Mar; 17(2):241-50. PubMed ID: 21604178 [TBL] [Abstract][Full Text] [Related]
2. Use of cystatin C levels in estimating renal function and prognosis in patients with chronic systolic heart failure. Damman K; van der Harst P; Smilde TD; Voors AA; Navis G; van Veldhuisen DJ; Hillege HL Heart; 2012 Feb; 98(4):319-24. PubMed ID: 22038544 [TBL] [Abstract][Full Text] [Related]
3. Renal tubular damage and worsening renal function in chronic heart failure: Clinical determinants and relation to prognosis (Bio-SHiFT study). Brankovic M; Akkerhuis KM; Hoorn EJ; van Boven N; van den Berge JC; Constantinescu A; Brugts J; van Ramshorst J; Germans T; Hillege H; Boersma E; Umans V; Kardys I Clin Cardiol; 2020 Jun; 43(6):630-638. PubMed ID: 32298007 [TBL] [Abstract][Full Text] [Related]
4. The cardiorenal syndrome in heart failure. Damman K; Voors AA; Navis G; van Veldhuisen DJ; Hillege HL Prog Cardiovasc Dis; 2011; 54(2):144-53. PubMed ID: 21875513 [TBL] [Abstract][Full Text] [Related]
5. Prognostic value of worsening renal function in outpatients with chronic heart failure. Pimentel R; Couto M; Laszczyńska O; Friões F; Bettencourt P; Azevedo A Eur J Intern Med; 2014 Sep; 25(7):662-8. PubMed ID: 24986374 [TBL] [Abstract][Full Text] [Related]
6. Utility of Cystatin C for Estimating Glomerular Filtration Rate in Patients With Muscular Dystrophy. Kimura K; Morita H; Daimon M; Horio M; Kawata T; Nakao T; Hirokawa M; Kitao R; Watanabe D; Komori T; Nagata T; Takeda S; Komaki H; Segawa K; Nakajima T; Takenaka K; Komuro I Int Heart J; 2016 May; 57(3):386-8. PubMed ID: 27170475 [TBL] [Abstract][Full Text] [Related]
7. Measuring renal function in acute heart failure: A place for old and new equations. Alvelos M; Couto M; Laszczyńska O; Almeida PB; Guimarães J; Azevedo A; Bettencourt P Int J Cardiol; 2015 Oct; 196():70-2. PubMed ID: 26073216 [No Abstract] [Full Text] [Related]
8. Renal dysfunction in acute heart failure: epidemiology, mechanisms and assessment. Carubelli V; Metra M; Lombardi C; Bettari L; Bugatti S; Lazzarini V; Dei Cas L Heart Fail Rev; 2012 Mar; 17(2):271-82. PubMed ID: 21748453 [TBL] [Abstract][Full Text] [Related]
9. Renal function largely influences Galectin-3 prognostic value in heart failure. Zamora E; Lupón J; de Antonio M; Galán A; Domingo M; Urrutia A; Troya M; Bayes-Genis A Int J Cardiol; 2014 Nov; 177(1):171-7. PubMed ID: 25499371 [TBL] [Abstract][Full Text] [Related]
10. Effect of renal function on prognosis in chronic heart failure. Löffler AI; Cappola TP; Fang J; Hetzel SJ; Kadlec A; Astor B; Sweitzer NK Am J Cardiol; 2015 Jan; 115(1):62-8. PubMed ID: 25465925 [TBL] [Abstract][Full Text] [Related]
11. Echocardiographic and Hemodynamic Parameters Associated with Diminishing Renal Filtration among Patients with Heart Failure with Preserved Ejection Fraction. Lo KB; Mezue K; Ram P; Goyal A; Shah M; Krishnamoorthy P; Gupta S; Pressman GS; Rangaswami J Cardiorenal Med; 2019; 9(2):83-91. PubMed ID: 30544108 [TBL] [Abstract][Full Text] [Related]
13. Worsening renal function during hospitalization in elderly patients with heart failure: an independent factor of activities of daily living decline. Kubo I; Izawa KP; Kajisa N; Ryu M; Akasaka H; Ogura A; Kanai M; Matsuzoe H; Matsumoto D Heart Vessels; 2021 Jan; 36(1):76-84. PubMed ID: 32720094 [TBL] [Abstract][Full Text] [Related]
14. Proenkephalin, an Opioid System Surrogate, as a Novel Comprehensive Renal Marker in Heart Failure. Emmens JE; Ter Maaten JM; Damman K; van Veldhuisen DJ; de Boer RA; Struck J; Bergmann A; Sama IE; Streng KW; Anker SD; Dickstein K; Lang CC; Metra M; Samani NJ; Ng LL; Voors AA Circ Heart Fail; 2019 May; 12(5):e005544. PubMed ID: 31091993 [TBL] [Abstract][Full Text] [Related]
15. Influence of renal function on the use of guideline-recommended therapies for patients with heart failure. Heywood JT; Fonarow GC; Yancy CW; Albert NM; Curtis AB; Stough WG; Gheorghiade M; McBride ML; Mehra MR; O'Connor CM; Reynolds D; Walsh MN Am J Cardiol; 2010 Apr; 105(8):1140-6. PubMed ID: 20381667 [TBL] [Abstract][Full Text] [Related]
16. Use of angiotensin-converting enzyme inhibitors in patients with heart failure and renal insufficiency: how concerned should we be by the rise in serum creatinine? Ahmed A J Am Geriatr Soc; 2002 Jul; 50(7):1297-300. PubMed ID: 12133029 [TBL] [Abstract][Full Text] [Related]
17. The significance of serum urea and renal function in patients with heart failure. Gotsman I; Zwas D; Planer D; Admon D; Lotan C; Keren A Medicine (Baltimore); 2010 Jul; 89(4):197-203. PubMed ID: 20616658 [TBL] [Abstract][Full Text] [Related]
18. The impact of kidney dysfunction categorized by urinary to serum creatinine ratio on clinical outcomes in patients with heart failure. Otaki Y; Watanabe T; Konta T; Tamura H; Kato S; Nishiyama S; Takahashi H; Arimoto T; Shishido T; Watanabe M Heart Vessels; 2020 Feb; 35(2):187-196. PubMed ID: 31332507 [TBL] [Abstract][Full Text] [Related]
19. Cystatin C in acute heart failure without advanced renal impairment. Naruse H; Ishii J; Kawai T; Hattori K; Ishikawa M; Okumura M; Kan S; Nakano T; Matsui S; Nomura M; Hishida H; Ozaki Y Am J Med; 2009 Jun; 122(6):566-73. PubMed ID: 19393984 [TBL] [Abstract][Full Text] [Related]
20. Renal function, congestive heart failure, and amino-terminal pro-brain natriuretic peptide measurement: results from the ProBNP Investigation of Dyspnea in the Emergency Department (PRIDE) Study. Anwaruddin S; Lloyd-Jones DM; Baggish A; Chen A; Krauser D; Tung R; Chae C; Januzzi JL J Am Coll Cardiol; 2006 Jan; 47(1):91-7. PubMed ID: 16386670 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]